Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Mizuho Maintains Neutral on Seagate Tech Hldgs, Lowers Price Target to $75

Mizuho Maintains Neutral on Seagate Tech Hldgs, Lowers Price Target to $75

Mizuho analyst Vijay Rakesh maintains Seagate Tech Hldgs (NASDAQ:STX) with a Neutral and lowers the price target from $83 to $75.

byBenzinga Newsdesk

September 1, 2022

1 minute read

Mizuho analyst Vijay Rakesh maintains Seagate Tech Hldgs (NASDAQ:STX) with a Neutral and lowers the price target from $83 to $75.

Rivian Recalls Nearly All Of EVs Deliveries To-Date Due to Fastener Issue

By Shanthi Rexaline

October 8, 9:24 AM

Rivian Automotive, Inc.’s (NASDAQ: RIVN) otherwise good week ended with some bad tidings for the electric vehicle manufacturer.

AMZN

News
Tech

Google Cements AI Presence With Latest Move: Integrates AI Research Divisions Google Brain, DeepMind

By Anusuya Lahiri

April 21, 7:32 AM

Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google DeepMind clubbed the AI research groups, the Brain team from Google Research, and DeepMind to accelerate…

GOOG

Analyst Ratings

Where Sonos Stands With Analysts

By Benzinga Insights

December 12, 8:00 AM

Over the past 3 months, 5 analysts have published their opinion on Sonos (NASDAQ:SONO) stock. These analysts are…

SONO

Molecular Partners Announces Publication In Cancer Immunology Research Of Preclinical Data Supporting MP0533’s Proposed Mechanism Of Action

By Benzinga Newsdesk

April 29, 11:01 AM

Preclinical data of tetra-specific T cell engager MP0533 demonstrate preferential T cell mediated killing of AML cells, while sparing healthy cells Results highlight MP0533-mediated T-cell activation and tumor

MOLN

Mizuho Maintains Neutral on Seagate Tech Hldgs, Lowers Price Target to $75

Related Posts

Rivian Recalls Nearly All Of EVs Deliveries To-Date Due to Fastener Issue

Google Cements AI Presence With Latest Move: Integrates AI Research Divisions Google Brain, DeepMind

Where Sonos Stands With Analysts

Molecular Partners Announces Publication In Cancer Immunology Research Of Preclinical Data Supporting MP0533’s Proposed Mechanism Of Action